Vanguard Group’s Silo Pharma SILO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$8.27K Buy
1,621
+532
+49% +$3.93K ﹤0.01% 4323
2025
Q3
$11.3K Hold
1,089
﹤0.01% 4338
2025
Q2
$10.3K Hold
1,089
﹤0.01% 4263
2025
Q1
$19.1K Hold
1,089
﹤0.01% 4249
2024
Q4
$14.5K Hold
1,089
﹤0.01% 4272
2024
Q3
$18K Hold
1,089
﹤0.01% 4308
2024
Q2
$16.3K Hold
1,089
﹤0.01% 4368
2024
Q1
$31.9K Hold
1,089
﹤0.01% 4355
2023
Q4
$23.5K Buy
1,089
+122
+13% +$2.77K ﹤0.01% 4432
2023
Q3
$24.2K Buy
+967
New +$28.8K ﹤0.01% 4483

Other funds holding SILO

Vanguard Group's SILO Position: Q4 2025 in Review

Vanguard Group increased its Silo Pharma (SILO) stake by 49% in Q4 2025, buying an estimated $3.93K and bringing the position to 1,621 shares worth $8.27K. The position accounts for ﹤0.01% of the portfolio, ranked #4323.

Vanguard Group first reported a position in SILO in Q3 2023 and has held it in 10 quarters since. The position peaked at $31.9K in Q1 2024. 15 funds tracked by Wall St. Rank hold SILO as of Q4 2025.

  • Vanguard Group held 1,621 shares of Silo Pharma worth $8.27K as of Q4 2025.
  • Vanguard Group bought 532 Silo Pharma shares in Q4 2025, an estimated $3.93K.
  • Silo Pharma made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4323 holding.
  • Vanguard Group first reported a position in Silo Pharma in Q3 2023 and has held it in 10 quarters since.
  • Vanguard Group's Silo Pharma position peaked at $31.9K in Q1 2024.
  • 15 funds tracked by Wall St. Rank held Silo Pharma as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.